Shuhui Wang Lorkowski

Title: Shuhui Wang Lorkowski: Innovator in Cardiovascular Health

Introduction

Shuhui Wang Lorkowski is a prominent inventor based in Shaker Heights, OH (US). She has made significant contributions to the field of cardiovascular health through her innovative research and patented technologies. Her work focuses on improving the assessment of cardiovascular risks, particularly in relation to major adverse cardiac events (MACE).

Latest Patents

Shuhui holds a patent for "ApoA1 exchange rate assays in serum." This patent encompasses compositions, systems, kits, and methods for performing an apoA1 exchange assay. The assay is designed to determine the risk of MACE and to facilitate actions based on the assay results. The methods provided in her patent include generating reports that graphically display the subject's ApoA1 exchange rate in comparison to control values, thereby indicating the risk of cardiovascular disease.

Career Highlights

Shuhui Wang Lorkowski is affiliated with the Cleveland Clinic Foundation, where she continues to advance her research in cardiovascular health. Her work is instrumental in developing tools that can help predict and manage cardiovascular risks effectively.

Collaborations

Shuhui collaborates with notable colleagues, including Jonathan D. Smith and Stanley Leon Hazen. These partnerships enhance the impact of her research and contribute to the advancement of cardiovascular health technologies.

Conclusion

Shuhui Wang Lorkowski is a trailblazer in the field of cardiovascular health, with her innovative patent addressing critical health risks. Her contributions are vital for improving patient outcomes and advancing medical research in this important area.